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structural bases of peptidoglycan 
recognition by lysostaphin SH3b 
domain
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Filip stefaniak  1, Dorota Niedziałek3, Matthias Bochtler  1,3 & Izabela Sabała1
Staphylococcus simulans lysostaphin cleaves pentaglycine cross-bridges between stem peptides in the 
peptidoglycan of susceptible staphylococci, including S. aureus. this enzyme consists of an N-terminal 
catalytic domain and a cell wall binding domain (SH3b), which anchors the protein to peptidoglycan. 
Although structures of SH3bs from lysostaphin are available, the binding modes of peptidoglycan to 
these domains are still unclear. We have solved the crystal structure of the lysostaphin SH3b domain 
in complex with a pentaglycine peptide representing the peptidoglycan cross-bridge. the structure 
identifies a groove between β1 and β2 strands as the pentaglycine binding site. The structure suggests 
that pentaglycine specificity of the SH3b arises partially directly by steric exclusion of Cβ atoms in 
the ligand and partially indirectly due to the selection of main chain conformations that are easily 
accessible for glycine, but not other amino acid residues. We have revealed further interactions of SH3b 
with the stem peptides with the support of bioinformatics tools. Based on the structural data we have 
attempted engineering of the domain specificity and have investigated the relevance of the introduced 
substitutions on the domain binding and specificity, also in the contexts of the mature lysostaphin and 
of its bacteriolytic activity.
Most peptidoglycan hydrolases, particularly those of phage origin, have modular structure and are built of at least 
one catalytic and one cell wall binding domain (CBD)1. So far, several different CBDs have been described in the 
literature, such as LysM2, Cpl-13, Cpl-7 domain4 and the family of bacterial SH3b domains1,5. Different CBDs 
recognize and bind noncovalently to various elements of the cell walls, like the peptidoglycan sugar backbone 
(LysM)6, choline (Cpl-1)3, teichoic acids (R domain)7, and peptidoglycan cross-bridges (SH3b)8. The specificities 
of CBDs vary considerably. Some are specific only for certain serovars, as in Listeria phage endolysins9,10, others 
recognize peptidoglycan elements characteristic for a whole genus, as SH3b domains in a variety of different 
peptidoglycan hydrolases.
SH3b domains that are present in many staphylococcal phage endolysins and some autolysins, are well con-
served11,12. These domains are necessary for accurate cell wall recognition8,13,14 and have been shown to recognize 
and bind glycine cross-bridges characteristic for most staphylococci15. By binding to receptors in the bacterial 
cell walls SH3b domains might regulate the activity of peptidoglycan hydrolases16. In our previous work we have 
demonstrated that addition of lysostaphin SH3b domain to the catalytic domain of LytM, an autolysin from S. 
aureus, made the enzyme more salt-tolerant17.
Structures of SH3b domains have so far been determined for Ale-18 and lysostaphin18, both in the absence of 
their ligands. Although regions of SH3b domains that contribute to the substrate specificity have been defined 
by mutagenesis experiments, the precise interactions between SH3b domains and peptidoglycan are still unclear. 
A better understanding of these interactions is desirable, because it may allow for engineering of the domain to 
broaden the range of targeted bacteria but also to overcome lysostaphin resistance, which is caused by introduc-
tion of serines into the cross-bridge19,20.
Here we present the first structure of bacterial SH3b domain in complex with pentaglycine and characterize 
binding of the domain to other elements of peptidoglycan using biophysical and biochemical methods supported 
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by bioinformatics tools and molecular dynamics. We show that these interactions are crucial for the function of 
lysostaphin and we attempt structure based engineering of the domain specificity.
Results
Overall structure of the lysostaphin SH3b domain. The structure of the SH3b domain of lysostaphin 
is very similar to its counterpart in the previously determined Ale-18 structure, as could be expected based on 
the high degree of sequence similarity between these domains (84% sequence identity over 90 residues) (Fig. 1).
As reported already for Ale-1, the prokaryotic SH3b domains are built of eight β-strands (β1–β8) that can 
roughly be divided into two sheets packed at the right angle against each other. The first sheet is made from 
β5–β7 and the N-terminus of β2, whereas the second sheet is made from β3-β4, β8 and the C-terminus of β2. 
The strands β1, β3 and β4 are unique to Ale-1 and lysostaphin SH3b domains, whereas the other β-strands are 
present in both, eukaryotic and bacterial domains (Fig. 2). The strands β3 and β4 are located in the so-called RT 
loop (following the nomenclature of the Ale-1 structure description). In canonical SH3 domains, this loop has 
been implicated in domain specificity21,22. Mutational data also support the role for the SH3b domain of Ale-1 in 
sequence specificity8,23. They implicate strands β1 and β2 in the binding, since a fragment lacking these strands is 
drastically impaired in specific binding to lysostaphin susceptible peptidoglycan, but not in background binding 
to other types of peptidoglycan8.
The overall structure of the lysostaphin SH3b domain in the presence of the pentaglycine ligand is very 
similar to the structure of the domain in the context of the full length protein, but in the absence of ligand18 
(r.m.s.d. value 0.7Å, main chain). The new lysostaphin SH3b structure is also very similar to the structure of 
S. capitis Ale-1 (r.m.s.d. value 0.9Å, main chain). The only variations are found in loop regions, mainly distal 
and extra loops. Also no differences were observed between the two molecules present in the asymmetric 
unit, the r.m.s.d. of 0.61Å was calculated for all atoms of chains A and B, and 0.22Å between two ligands 
Figure 1. (A) Structural comparison of the lysostaphin SH3b domain in complex with the pentaglycine peptide 
(dark green; PDB 5LEO) with the SH3b domains of Ale-1 (gray; PDB 1R77) and the apo-lysostaphin (brown; 
PDB 4LXC). (B) Alignment of amino acid sequence of SH3b domains from lysostaphin and Ale-1. Residues 
involved in interactions with pentaglycine are marked as red.
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(chains G and H). These comparisons indicate that there are no significant differences between the structures 
of Ale-1 and lysostaphin SH3b domains, and that pentaglycine binding does not induce significant structural 
change (Fig. 1).
Figure 2. Cartoon representation and topology of the lysostaphin SH3b (green) and eukaryotic SH3 domains (blue).
Figure 3. Structure of lysostaphin SH3b domain in complex with pentaglycine. (A) front view, (B) Close up 
view of residues interacting with the pentaglycine peptide, (C) Calculated composite omit electron density map 
of pentaglycine at 1 σ.
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pentaglycine binding mode. The structure of the SH3 domain of lysostaphin (PDB ID: 5LEO) is inform-
ative beyond what could have been predicted by bioinformatic analysis alone, because it elucidates the binding 
mode of pentaglycine to the SH3b domain at high resolution, and with a good definition of the bound peptide 
along its entire length (real space correlation coefficients >0.85 for all five glycines). The side and bottom walls of 
the binding grove are built of side chains of residues Asn405, Tyr407, Thr409, Tyr411, Thr429, Gly430, Pro431, 
Phe432, Met435, Glu451, Met453, and Tyr472. The bound pentaglycine molecule adopts an extended confor-
mation, in between strands β1 and β2 on the one side and the RT loop on the other side. As both elements of the 
SH3b domain have previously been implicated in peptidoglycan binding in the case of the Ale-1 SH3b domain8, 
it is likely that the pentaglycine binding mode that is observed in the crystals is physiologically relevant. The 
pentaglycine peptide runs approximately parallel to β1 and anti-parallel to β2, but there are no β-strand specific 
main chain hydrogen bonding contacts, because the distance is too large. Instead of interacting with the main 
chain, the pentapeptide interacts with side chains from both β1 and β2 and from the RT. Due to the lack of back-
bone interactions, pentaglycine can adopt a non-canonical secondary structure characterized by carbonyl groups 
that are neither parallel (as in α-helices) nor alternatingly antiparallel (as in β-strands).
structural determinants of interactions with pentaglycine. In the crystal structure, Gly1 exposes 
an N-terminal α-amino group, which forms a salt bridge with a sulfate or phosphate ion from the crystallization 
buffer, which is also involved in inter-subunit contacts (that are different for the two SH3b monomers in the 
asymmetric unit). In peptidoglycans the N-terminal amino group of Gly1 should be connected in amide linkage 
with the carboxylate group of the D-Ala residue of the stem peptide, therefore this interaction is a crystal artifact. 
However, as the sulfate or phosphate is bound on the surface, its presence shows that there is space on the SH3b 
domain for the stem peptide that would be upstream of the pentaglycine in a peptidoglycan context. The carbonyl 
oxygen atom of Gly1 accepts a hydrogen bond (donor-acceptor distance 3.1Å) from the side chain carboxamide 
of Asn405, located at the end of β1. The Asn405 carboxamide is similarly close to the carbonyl oxygen atoms of 
Gly2 and Gly3, but the geometry is not compatible with hydrogen bonding. The carbonyl oxygen atom of Gly2 
accepts instead an indirect, water mediated hydrogen bond from Thr409. Gly2 is additionally held by a hydrogen 
bond from its NH group to the carboxylate group of Glu451, which is anchored in a region of the SH3b domain 
not previously implicated in peptidoglycan binding. Moreover, the amide bond between Gly1 and Gly2 packs at 
van-der-Waals distance against the side chain of Tyr411 of β2. The conformation of Gly3 appears to be primar-
ily determined by its covalent linkage to the upstream and downstream residues of the pentapeptide. The Gly3 
NH group points towards solvent and hydrogen bonds to a water molecule. The carbonyl group comes within 
hydrogen bonding distance to the ND2 atom of Asn405, but the geometry does not appear to be compatible with 
hydrogen bond formation. The position and orientation of the carbonyl group of Gly3 is rather determined by 
the hydrogen bond that Gly4 NH donates to the main chain carbonyl oxygen atom of Thr429 of the RT loop. The 
carboxyl oxygen atom of Gly4 accepts a water-mediated hydrogen bond to Thr409. The threonine residue and 
water molecule that are involved in anchoring the carbonyl oxygen of Gly4 are the same ones that also anchor 
the carbonyl oxygen atom of Gly2. The threonine residue and water molecule therefore appear to have a central 
role in defining the pentapeptide conformation. Gly5 stacks against the aromatic ring of Tyr407, but it does not 
engage in hydrogen bonding interactions with the SH3b domain that is bound to, but forms a salt bridge between 
its carboxylate group and an arginine of a neighboring molecule in the crystal (Fig. 3).
Characterisation of binding. MST (microscale thermophoresis). Fluorescently labelled LssSH3b was 
incubated with GGGGG, GGSGG or AQKAA (stem peptide). Unspecific binding was monitored using peptide 
GRGDS. Specific interactions were observed for pentaglycine but due to limited solubility of this peptide and 
weak affinity the full binding curves necessary for calculation of Kd could not be recorded. However, it could 
still be concluded that interactions of LssSH3b domain with short peptidoglycan fragments are weak (milimolar 
range) for both the stem peptide and pentaglycine. Substitution of middle glycine with serine in GGSGG peptide 
reduced the interactions even further (Supp. Fig. S1).
Scatchart analysis. To evaluate the strength of SH3b domain binding to whole cells Scatchard analysis was per-
formed. The Scatchard plots of different strains of S. aureus yielded straight lines (Supp. Fig. S2) from which a Kd 
was estimated to be in the micromolar range (Table 1). Substitution of one of the glycines in the bridge with serine 
(TF5311 strain) weakens the binding affinity as compared to parental stains with penatglycine bridge (TF5303 
strain). For S. aureus mutants femB and femAB with shortened cross-bridges, the binding affinity could not be 
determined due to very weak signals.
Strain (bridge 
structure) Kd(µM)
Number of SH3b molecules 
attached to single bacterial cell
8325-4 (GGGGG) 1,95 ± 0,28 0,65 ± 0,18*106
TF5303 (GGGGG) 1,02 ± 0,63 0,46 ± 0,36*106
TF5311 (GGSGG) 2,23 ± 0,03 0,36 ± 0,08*106
femB (GGG) nd nd
femAB (G) nd nd
Table 1. Results of Scatchard analysis of SH3b_GFP binding to various strains of S. aureus.
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As defined numbers of S. aureus cells were used, we could calculate that at most between 105 and 106 SH3b_
GFP could be bound to a single S. aureus cell (Table 1). These numbers correspond to the results of other esti-
mation based on lysostaphin activity inhibition by preincubation of bacterial cells with Lss SH3b domain. The 
number of SH3b molecules bound to a single cell in those experiments ranged between 105–106, assuming the 
number of given cells and SH3b concentration which nearly completely reduced Lss activity (Supp. Fig. S3).
Bioinformatic analysis. The binding affinity of entire cells appeared to be much higher than the one of just iso-
lated peptides representing cross-bridges, which suggests that SH3b domain might interact also with other than 
pentaglycine elements of the peptidoglycans. Considering the size of the domain and the high level of staphylo-
coccal peptidoglycan crosslinking24, the SH3b domain may interact with the dense peptidoglycan network not 
only in the vicinity of the binding cleft for pentaglycine but in other areas of the protein surface as well.
To predict potential additional peptidoglycan interaction regions on the surface of the SH3b domain the 
DoGSiteScorer webserver was used25 (Fig. 4).
The main predicted binding pocket (pocket a in Fig. 4) with the highest volume, surface and drug score 
matches perfectly the binding groove occupied by pentaglycine in the complex structure. Three additional pock-
ets (pockets b, c, d in Fig. 4) also scored highly suggesting that there is a very high probability of binding peptido-
glycan network in those regions of the SH3b domain.
Molecular modeling. To ensure the validity of the proposed binding mechanism and analyze further inter-
actions of the SH3b domain with other elements of peptidoglycans, namely stem peptides, we have complemented 
our studies by combining molecular docking and Molecular Dynamics (MD) simulation techniques. During both 
types of modeling, we assumed a full flexibility of the ligand, having in mind that it may be reduced in case of 
the potentially more rigid PG network (for details, see “Molecular modeling of the SH3 domain-peptidoglycan 
complex” section in Materials and Methods).
Simulations with pentaglycine bound to the SH3b domain identically as in the 5LEO structure, revealed 
instability of this complex, due to a very high flexibility of the pentaglycine chain, what immediately lead to the 
dissociation of the pentaglycine molecule from the binding pocket already at room temperature. Similarly, stem 
peptides alone (not connected via pentaglycine bridge) were not able to remain bound with the SH3b protein 
domain at room temperature (data not shown).
Much stronger binding was predicted for the whole fragment of the peptidoglycan comprising pentaglycine 
linking two stem peptides. We docked a three-dimensional model of a PG fragment (Fig. 5A) to the crystal struc-
ture of the SH3b domain. To assess the stability of the predicted SH3b-ligand complex, MD simulations were 
performed. Simulations carried out at room temperature confirmed the stability of the complex predicted by 
Figure 4. Peptide binding sites on the surface of lysostaphin SH3b domain predicted using DoGSiteScorer 
webserver.
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molecular docking (Fig. 5B). In this pose, the pentaglycine bridge of the PG-fragment (Fig. 5, marked as yellow) 
remains within the binding pocket occupied by GGGGG in our crystal structure (PDB ID: 5LEO) and stem pep-
tides are oriented toward predicted binding pockets.
To explore further the conformational space of the PG fragment upon interaction with the SH3b domain, 
we performed MD analyses at higher temperatures (Fig. 5C,D). Although the stem peptides of the PG fragment 
fluctuated significantly during the dynamical evolution of the SH3b-PG fragment complex already at room tem-
perature (RT), the pentaglycine bridge remains within the binding pocket of the SH3b even at higher (i.e. >300 K) 
temperatures.
Figure 5. (A) Structure of ligand (PG fragment) used for modeling. Background colors (cyan for the 
cross-linked stem peptide, yellow for the pentapeptide bridge, orange for the bridge-linked stem peptide) 
corresponds to colors of the ligands’ main chain in the panels (B–E). Dashed arrows indicate directions of the 
peptidoglycan network. The terminal amino groups of the fragments used for modeling were charged, however 
in the muramoyl-linked stem peptide in the peptidoglycans, these groups are neutral (B–E). Predictions 
of the binding modes of PG-ligands with SH3b domain of lysostaphin: PG-fragment (B–D) and PG-G3S 
fragment (E). Poses B and E had been initially obtained using molecular docking and then confirmed as stable 
conformations by Molecular Dynamics simulations. Poses C and D have been obtained and confirmed as stable 
during Molecular Dynamics exploration of the conformational space of the PG-fragment upon binding SH3b.
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As can be seen in Fig. 5, the bridge-linked stem peptide always occupies the same part of the SH3b surface in a 
conformation maximizing the hydrogen bonding, which is located in a groove formed between β7 strand and RT 
loop. On the contrary, the cross-linked stem peptide can adopt different conformations interacting via hydrogen 
bonds with different parts of SH3b surface. The conformation of the cross-linked stem peptide mostly depends 
on the C1-Cα torsional angle on the Gly1 residue of the pentaglycine allowing this stem peptide to accommodate 
in the groove formed within the β1 strand (Fig. 5a) or in the located ~10Å away and biggest detected binding 
pocket (Figs 4b and 5b–d). The dynamical evolution between the PG-fragment conformers will be discussed in 
detail later.
Bioinformatic tools helped to analyze the consequences of substituting the middle glycine with serine, which 
is known mechanism of SH3b binding inhibition20. Replacing the Gly3 of the pentaglycine ligand by serine leads 
to: (i) a discernible steric hindrance by the hydroxymethyl side chain, (ii) induced stiffness in the middle of the 
ligand, and (iii) disturbance of the specific hydrogen bonds network between the SH3b and the bridge. Moreover, 
the Gly3 replacement by serine (iv) allows for intramolecular hydrogen bond interactions between the hydrox-
ymethyl side chain and the main chain of the ligand. Such bonding increases stiffness and causes adverse confir-
mation of the GGSGG ligand. All these factors lead to a significant decrease in both specificity and stability of the 
SH3b-GGSGG complex with respect to SH3b-GGGGG, which is manifested by a hindered binding and immedi-
ate dissociation of the primary complex. Analogous effects were observed when the Gly3 residue was replaced by 
serine in the pentaglycine bridge of the PG fragment, though they did not lead to the dissociation of the complex. 
This additional stability was a result of the interactions (mostly via hydrogen bonds) between the SH3b domain 
and the stem peptides. These interactions also increase the affinity of the complex by playing a role of additional 
recognition sites. Moreover, the serine substitution in the middle of the pentaglycine bridge allows for intramo-
lecular hydrogen bonding between the serine’s hydroxyl group and carbonyl groups of flanking glycines.
In summary, the Gly3 replacement by serine significantly influences the conformational properties of both 
bridge alone and PG-G3S fragment.
SH3b mutagenesis. One of the concerns related to application of lysostaphin as an effective antimicrobial 
agent is resistance observed when cross-bridge glycines are replaced by other amino acids, in most cases serine at 
position 3. Such altered cross-bridges are much less prone to lysostaphin cleavage due to deceased susceptibility 
of such substrates to catalysis but also because of reduced binding of the SH3b domain26.
Our structure analysis reveals two main residues building the binding groove around Gly3 of the bound 
pentaglycine: asparagine 405 (Asn405) and tyrosine 472 (Tyr472). While Asn405 seems to play a major role in the 
pentaglycine binding, in silico substitution of Gly3 to serine indicates possible clashes also with the side chains of 
Tyr472. We assumed that shortening the side chain of Tyr472 might generate more space for accommodation of 
serine at position 3 in the cross-bridge, and replacing Asn405 with alanine could allow for binding peptide less 
flexible than pentaglycine. To test the relevance of Asn405 and Tyr472 in substrate recognition and binding these 
two residues were substituted with alanine in single and double variants. This mutagenesis was performed both 
on LssSH3b fused to GFP to characterize binding properties and on mature lysostaphin to test their effect on lytic 
activity of the enzyme. Activity and binding assays were performed on S. aureus reference strain but also mutants 
with serine introduced in the cross -bridge and cross-bridges shortened to three or one glycine.
Effect of substitutions on SH3b binding. Fluorimetric assays with LssSH3b_GFP fusion protein were 
run to characterize specificity of LssSH3b (lysostaphin SH3b domain) binding to bacterial cells. Only background 
fluorescence was observed after incubation with GFP alone. Therefore signals detected in samples after incu-
bation with LssSH3b_GFP could be attributed to specific binding of LssSH3b but not of GFP to the bacterial 
cell walls (Fig. 6). This was also confirmed by microscopic observations which demonstrated that the LssSH3b 
Figure 6. Fluorimetric binding assay of wild type LssSH3b_GFP and its variants (N405A, Y472A, N405/Y472) 
with various strains of S. aureus which represent wild type (pentaglycine) or altered cross-bridges. Results were 
normalized to the % of binding of wild type LssSH3b_GFP domain to wild type S. aureus NCTC 8325-4 (100%). 
The error bars represent standard deviation calculated for three experiments each run with triplicates.
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domain binds specifically to the cell walls of S. aureus. No fluorescence was observed either on the surface of 
E. coli after incubation with the fusion protein or S. aureus incubated with GFP alone (Fig. S4).
The results confirm that LssSH3b domain binds specifically to S. aureus and that the efficiency of the binding 
depends on the length and composition of the cross-bridges, as illustrated by decreased level of fluorescence 
detected in assays with S. aureus strain femB and femAB with shortened cross-bridges (3 or 1 glycine, respectively) 
and strain TF5311, in which one of the glycines in the cross-bridge is replaced by serine (Fig. 6).
We have engineered variants of LssSH3b domain with predicted wider pentaglycine binding groove by sub-
stituting asparagine 405 (Asn405) and tyrosine 472 (Tyr472) by alanines. The introduced substitutions reduced 
binding by approximately 20–30% as compared to the wild type domain (Fig. 6). The impaired binding of the 
WT LssSH3b to femB mutant of S. aureus was not rescued by the single substitution introduced while double one 
rescued the negative effect of single substitutions and bound S. aureus femB mutant with the same efficiency as the 
WT protein. A similar effect was observed for strain with serine introduced in the cross- bridges. The only case of 
improved binding was observed for a double LssSH3b substitution and an S. aureus strain with single glycine in 
the cross-bridges (femAB) as compared to the WT S. aureus (8325-4 strain).
Effect of amino acid substitutions on lysostaphin activity. To test the relevance of the selected resi-
dues in LssSH3b domain for the activity of lysostaphin the corresponding single and double substitutions, N405A 
and Y472A, were introduced in the background of mature enzyme.
When the standard concentration of purified enzymes (100 nM) was used, no differences were observed in 
lysis of the S. aureus with different length of cross-bridges between the native and lysostaphin with introduced 
substitutions. In the next step the concentration of the enzymes was reduced 10 fold to detect subtler differences. 
Even in such stringent test conditions variants with single substitutions behaved the same as the WT protein. 
Y472A variant turned out to be slightly more efficient in lysing femB mutant strain than the WT enzyme and 
N405A/Y472A variant was more active against femAB mutant strain (with single glycine in the cross-bridges). We 
concluded that although the residues Asn405 and Tyr472 are involved in peptidoglycan binding, their replace-
ments with alanine do not affect lytic activity of the mature lysostaphin significantly, at least in the assays and 
conditions used (Fig. 7A).
Apart from revealing the role of selected residues on peptidoglycan binding we were also expecting that these 
changes might expand the activity of lysostaphin resistant strains having serine in the cross-bridges. No activity 
of the WT or any of the variants was detected when 10 nM enzymes were used in the assays with S. aureus strain 
TF5311 carrying epr gene responsible for introduction of serine(s) in the cross- bridges. Therefore the lytic tests 
were run with 100 nM lysostaphin and its variants, which all demonstrated the same, full activity toward the wild 
type strain (TF5303). Both WT lysostaphin and Y472A variant displayed approximately 40% decrease of the 
lytic activity towards the TF5311 strain, while in the case of variant carrying N405A substitution this efficiency 
dropped further 20%. These results clearly show that the effect of shortening the side chain of residue 472 side 
chain is rather negligible while substitution of asparagine N405 by alanine (N405A) impairs significantly the lys-
ostaphin activity. None of the introduced substitution expanded the activity of the enzyme to lysostaphin resistant 
strain (Fig. 7B).
Discussion
Structural basis of pentaglycine specificity. Analysis of the structure explains the preference of the 
lysostaphin SH3b domain for glycine residues. Such preference could be reinforced indirectly, by requiring the 
bound peptide to be in a conformation only accessible to glycine residues. Alternatively, the preference for glycine 
residues could be enforced more directly, by steric clashes of the Cβ atom present in all other amino acids with 
residues of the SH3 domain. The question whether an additional Cβ atom could be accommodated in the crystal 
Figure 7. Lytic activity of lysostaphin with substituted residues in SH3b domain. (A) 10 nM enzymes activity 
was measured within 2 h at room temperature, (B) 100 nM enzymes activity was measured within 1 h at room 
temperature. Results present the percentage of reduction of initial OD600 (mean value from 3 independent 
experiments in triplicates, error bars represent standard deviation).
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structures can be addressed for all five glycine residues in the ligand, whereas Ramachandran angles are only 
defined for Gly2, Gly3 and Gly4 for the pentapeptide. Gly1 would have defined Ramachandran angles in the con-
text of a larger pentapeptide fragment. For Gly5, which is isopeptide-linked to the lysine side chain amino group 
of a stem peptide, at best an analogous measure to the Ramachandran angles could be defined.
For the first residue of the pentapeptide, in silico analysis places a potential Cβ atom too close to Tyr411. The 
shortest distance (2.3Å or 2.6Å, depending on which molecule of the asymmetric unit is analyzed) is clearly 
shorter than the sum of van der Waals radii of the CH2 and CH3 groups (1.7Å + 2.0Å = 3.7Å). The steric conflicts 
are thus sufficiently severe to be potentially biologically relevant according to a recent analysis of such clashes that 
allows for protein and ligand adaptive fit.
However, we note that the side chain of Tyr411 is not obviously anchored and may give way to some extent to 
make space for a larger residue.
In the crystal structure Gly2 adopts a rare left-handed α-helix conformation that is in principle also accessible 
to amino acids other than glycine. Modeling of a substitution of Gly2 to an alanine in this position introduces 
a Cβ atom close to Tyr411 (shortest distance ca. 2.8–2.9Å, depending on the molecule that is analyzed in the 
asymmetric unit).
Gly3 is placed in a region of the Ramachandran plot (ψ ~ 0, χ ~ 80°) that is favorable for glycine residues, but 
not accessible to other amino acids. Moreover, a Cβ atom on this residue would also come close to several atoms 
of Tyr472 (shortest distances 2.8–2.9Å). This is consistent with the observation that a change from glycine to 
serine in the peptidoglycan of lysostaphin-resistant staphylococci protects against lysostaphin activity and dimin-
ishes binding to the SH3b domain14,23.
Gly4 adopts a main chain conformation that is on the edge of the β-sheet region of the Ramachandran plot for 
all amino acids, but in the favored region for glycine. Any side chain on this residue would point towards solvent, 
and could therefore be easily accommodated.
The Gly5 main chain conformation is at the edge of the β-sheet region. A potential Cβ atom would be placed 
2.7–2.8Å away from Tyr407. However, the Gly5 conformation is in part dictated by a salt bridge between the 
glycine carboxylate and the guanidino group of an arginine (Arg476) of a crystallographic neighbor. Moreover, 
the free carboxylate group would be replaced by a carboxamide in a larger peptidoglycan fragment. Therefore, the 
conformation of Gly5 may not be representative for the conformation of this residue in peptidoglycan.
In summary, we conclude that pentaglycine specificity appears to result from a combination of direct and indi-
rect effects. The replacement of glycines in the pentapeptide by other residues would lead to clashes with N405 
and Tyr472, but possibly also with Tyr407 and Tyr411. Tyr411 is conserved among the staphylolytic enzymes (lys-
ostaphin, Ale-1, S. aureus autolysin, S. aureus phage Twort amidase, and S. aureus phage PVL amidase). Tyr407 
is present in all members of the group with the exception of the PVL amidase. Indirect selection for glycine by 
selection of a main chain conformation only accessible to glycine is clear-cut in case of Gly3, but may also operate 
to a lesser extent for other glycine residues.
Interactions beyond the pentaglycine. Both MST analysis and MD calculations shows that interactions 
between the short fragments of peptidoglycans (pentaglycine, stem peptide) are weak. Similarly, NMR titration 
experiments also indicated a milimolar value of Kd for pentaglycine binding to the lysostaphin cell wall binding 
domain27 and other bacterial SH3b domains28,29. In contrast, the affinities calculated for LssSH3b binding to PG 
fragment comprising two stem peptides bridged by pentaglycine (MD) and entire bacterial cells (Scatchart anal-
ysis) indicated much stronger interactions. Micromolar Kd values indicate strong interactions of the domain with 
the peptidoglycan network and intact bacterial cell walls and are in the range of affinities reported for other cell 
wall binding domains, like LysM6,30,31. The highly specific binding domains e.g. CBD from Listeria have Kd values 
calculated in pico- to nanomolar range10.
According to available crystal structures, the peptide binding grooves of bacterial and eukaryotic SH3 
domains are in different locations. The eukaryotic binding groove is located on the opposite side of the domain, 
as compared to pentaglycine binding groove bacterial domain (Fig. S7). Moreover. it is covered by the extended 
N-terminal characteristic for bacterial SH3b domains and therefore not accessible for ligands. Therefore, we have 
attempted modelling of peptidoglycan binding beyond already characterized interactions with pentaglycine 
based on available structural information and binding pocket predictions.
The predicted alternative conformations of the stem peptides differ mainly in the binding mode of the 
cross-linked stem peptide. The structural strains within the PG-fragment caused by conformational changes of 
the stem peptides and further propagated towards the flexible bridge get defused by structural readjustments 
of pentaglycines. The dynamical evolution from one pose to another happened mostly via rotation around the 
C1-Cα bond of the Gly1 residue of the pentaglycine bridge from 0 to 180 degrees and formation of cis peptide 
bonds which remains stable during a simulation process, even in high temperatures. The outstanding flexibility of 
the pentaglycine contributes to the PG-fragment’s extraordinary ability to adopt cis conformations of the peptide 
bonds. Cis bonds constitute a very small fraction of all peptide bonds. Recently, there have been several reports 
on presence and relevance of cis configuration of isopeptide bonds in Gram-positive bacteria that may use such 
intramolecular crosslinks as a mode of stabilization of cell surface structures and proteins32–37.
Interestingly, these strong changes in the geometry of the ligand did not correspond to any drastic structural 
changes in the SH3b domain. The only perceivable changes concerned the rearrangement of the non-bonding 
interactions within the SH3b-PG fragment complex, mostly the hydrogen bonds.
In summary, our modelling defines possible stable poses of the PG fragment bound to the SH3b domain, 
which map the area of interactions between the domain and the peptidoglycan stem peptides and reveal possible 
mechanisms of structural adaptation of the ligand by bond rotations and cis bond formation. Our predictions are 
similar to the ones published recently, although in both cases the predicted regions of stem peptides interactions 
do not overlay with the regions postulated based on NMR studies27 (Fig. S8).
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Substrate selectivity versus binding affinity. The main concern related to application of lysostaphin as 
an antimicrobial is resistance, which already exists in nature. The mechanism of resistance relies on substitution 
of the glycine(s) from the cross-bridge by serine(s). The lysostaphin producer – Staphylococcus simulans has such 
cross-bridges as a natural defense mechanism against lysostaphin.
Substrate selectivity of lysostaphin SH3b domain was confirmed by our assays with synthetic peptides, which 
demonstrated clearly that SH3b domain binds to pentaglycine while binding to GGSGG was not detected with the 
method and conditions used. However, when the SH3b was tested on intact cells of S. aureus strain TF5311 car-
rying epr gene responsible for lysostaphin resistance binding was substantially inhibited, but not completely abol-
ished. A similar extent of binding inhibition of peptidoglycans with serine modified cross-bridges was observed 
previously for both domains of lysostaphin and zoocin38,39, as well as in the case of Ale-1 binding domain8. These 
differences in binding to isolated pentapeptides and peptidoglycans/cells may be attributable to the heterogeneity 
of the cross-bridges in the strains used, as it cannot be excluded that there are still some pentaglycine bridges pres-
ent in the cell walls which serve as receptors for the SH3b domain. In fact, S. aureus strains carrying the epr gene, 
such as TF5311 used in this studies, have been shown to have heterogeneous cross-bridges including fraction of 
pentaglycine40. Alternatively, loss of binding of SH3b domains to serine containing cross-bridges may be at least 
partially overcome by interactions of the domain with other parts of the peptidoglycans, which might not define 
specificity but could play a role in determination of binding affinity. Similarly to our observations, substitution of 
the asparagine in SH3b domain from LysGH15 lysine corresponding to N405 in lysostaphin SH3b domain had a 
significant effect on peptidoglycan binding which was much less pronounced in the lytic activity assays28.
Mature lysostaphin – binding and activity. When superimposed on the crystal structure of lysostaphin 
the two pentaglycines from the complex of catalytic domain of LytM with substrate analogue41 and the SH3b 
complex bind in approximately antiparallel orientation and are located on opposite sides of the protein molecule 
(Fig. 8). The NMR structure of lysostaphin solved recently (PDB:5NMY) shows even more flexibility of the linker 
and the whole range of positions the two domains can adopt in relation to each other27.
It has been demonstrated that the isolated catalytic domain of lysostaphin is less effective in lysing staphylo-
coccal cells compared to mature lysostaphin, where it is accompanied by SH3b domain and that the activity can 
be detected only in low ionic strength conditions16,17. This indicated that decreased efficiency in cell lysis is due 
to impaired binding of the separate domain. Though it has been suggested that pentaglycine is the element of the 
staphylococcal cell wall necessary for SH3b binding13, we have demonstrated that this domain interacts also with 
other elements of the staphylococcal peptidoglycans. The SH3b domain does not only determine lysostaphin 
specificity, it contributes also significantly to the binding affinity of the entire enzyme which results in increased 
lytic efficiency. The anchoring of the enzymes to peptidoglycans in a specific location might lead to punctual 
lysis pattern which should deteriorate bacterial cell walls more effectively than bond cleavage scattered all over 
peptidoglycans18,42,43. As can be concluded from the analysis of the mature lysostaphin structure, the presence of 
a very flexible linker allows the catalytic domain to reach several cross-bridges when anchored to PG by the SH3b 
domain18,27.
Figure 8. Binding of mature lysostaphin to pentaglycine. Two molecules in the asymmetric unit of the mature 
lysostahin (PDB:4LXC) were superimposed to show the flexibility of the domains. The catalytic domains (yellow 
and gray) differ in orientation by almost 100°. Catalytic zinc ion shown as a ball and SH3b domains are green. 
Moreover, the structure of mature lysostaphin was superimposed with ligands from complex structures of LytM 
catalytic domain with substrate analogue (PDB:4ZYB) and LssSH3b domain with pentaglycine (PDB:5LEO).
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Materials and Methods
Protein overexpression and purification. A DNA fragment encoding residues 402–493 of lysostaphin 
was cloned into a pET15b expression vector using NcoI and XhoI restriction sites. The protein was overexpressed 
in E. coli BL21(DE3) in LB medium by induction with 0.1 mM IPTG for 6 h in 25 °C. The cell pellet was sus-
pended in 20 mM Tris-HCl pH 7.0, 1 M NaCl, 10% glycerol and disrupted with a Constant Cell Disruption System 
(Constant Systems Ltd.). The cell lysate was dialyzed against 20 mM Tris-HCl, pH 7.0, 50 mM NaCl. SH3b was 
purified by ion exchange chromatography on WB40S resin (Bio-Works, Uppsala, Sweden), eluted with about 
0.5 M NaCl in 20 mM Tris buffer pH 7.0, followed by gel filtration on Superdex 75 column (GE Healthcare) in 
20 mM Tris-HCl, pH 7.0, 50 mM NaCl buffer.
protein crystallization and structure determination. Purified Lss SH3b (70 mg/ml) was preincubated 
with 17 mM pentaglycine for 30 min at room temperature prior crystallization. Crystals were formed in crystal-
lization buffer from Morpheus Screen (Molecular Dimensions) composed of Buffer system 3 (0.1 M Tris (base), 
Bicine buffer, pH 8.5), 0.09 M NPS (NaNO3, Na2HPO4, (NH4)SO4), 37.5% MPD (racemic), PEG 1000, PEG 3350 
within two weeks. Crystallization trials were carried out by the vapour diffusion method in sitting drops at 18 °C. 
Crystals were cryoprotected directly from the crystallization drop.
The datasets were collected at beamline ID29 of European Synchrotron Radiation Facility (ESRF, Grenoble, 
France). The best crystals diffracted to around 1.6Å and the data were processed and scaled with XDS44. The sta-
tistics of the diffraction data are summarized in Table S1. The orthorhombic crystals that belong to space group 
P212121 contained two SH3b domain-pentaglycine complexes in the asymmetric unit. Structure was solved by 
molecular replacement with the fragment of previously published lysostaphin structure (4LXC) covering the cell 
wall binding domain (residues 402–493)18 using Phaser-MR module in Phenix45. The model was completed by 
the manual addition of the pentaglycine molecules. Interactive model building was performed in COOT46 and 
refinement with Phenix45. Structure validation was carried out using Molprobity analysis47. Structural analyses, 
including superpositions, and structural figures were prepared in Pymol (http://www.pymol.org). The r.m.s.d. 
for chains A and B (SH3b domain) is 0.61Å for all atoms, r.m.s.d. between pentaglycines (chain G and chain H) 
was 0.22Å for all atom). As the two complexes in the refined model have nearly identical conformation they can 
therefore be described together.
Mutagenesis. Lysostaphin SH3b domain variants with single residue substitutions: N405A and Y472A 
were generated by PCR-based site-directed mutagenesis according to the manufacture protocol with Phusion 
high-fidelity DNA polymerase (Thermo Scientific) using pET15b_SH3b plasmid as a PCR template. Mutations 
were confirmed by sequencing. The proteins with substitutions introduced were overexpressed and purified using 
the same protocols as for WT protein.
GFp fusion. In order to express GFP tagged protein, lysostaphin SH3b domain was cloned into XhoI/BamHI 
site of pWALDO vector48 and LssSH3b_GFP fusion protein with C-Histag sequence was overexpressed in 
E. coli BL21(DE3) under T7 promoter. The protein was expressed in LB upon induction with 0.1 mM IPTG at 
30 °C for 18 hours. The collected cells were sonicated and the lysate was applied on Ni+ column (HiTRAP, GE 
Healthcare). The imidazole gradient was run from 10 mM to 0.5 M in 20 mM Tris-HCl pH 8.0, 1 M NaCl, 10% 
glycerol. Histidine tagged LssSH3b_GFP protein eluted at 0.2 M imidazole was further purified by gel filtration 
on Superdex 75 column (GE Healthcare) in 20 mM Tris-HCl pH 8.0, 0.2 M NaCl, 10% glycerol. The gene for con-
trol GFP protein was cloned into NdeI/XhoI site of pET22b vector and GFP protein with C-Histag sequence was 
overexpressed in E. coli BL21(DE3) under T7 promoter. The expression was induced in LB medium with 1 mM 
IPTG at 28 °C for 18 hours and GFP protein was purified using the protocol optimized for LssSH3b_GFP fusion 
protein described above.
Fluorescent binding assay. Cells of S. aureus grown in TBS and E. coli grown in LB were harvested from 
overnight or from log phase cultures by centrifugation and resuspended to OD600 of 20 in PBS. 130 µl of the 
bacterial suspension was mixed with various amounts of LssSH3b_GFP ranging from 1 to 23 µg in a final volume 
of 150 µl. After 15 minutes incubation at room temperature the reaction mix was centrifuged. Bacterial cell pellets 
were washed twice with 100 µl of PBS and finally resuspended in 50 µl PBS. Fluorescence was measured in 50 µl 
of suspension, supernatant and resuspended palettes. As controls mixtures of staphylococcal cells incubated with 
GFP and E. coli cells mixed with LssSH3b_GFP or GFP were used. The fluorescence intensity was measured in 
Tecan Infinite M1000 plate reader in 96 well plates using excitation at 480 nm and emission at 508 nm. All exper-
iments were repeated at least twice.
Microscopy. Cells of S. aureus 8325-4 and E coli from overnight culture were harvested by centrifugation and 
resuspended to OD600 of 20 in PBS. 40 μl of the bacterial suspensions were mixed with 15 μg of LssSH3b_GFP 
fusion protein or 10 μg of GFP. After 15 minutes incubation at room temperature cells were sedimented by cen-
trifugation, washed twice with PBS and finally resuspended in 50 μl of PBS. Bacterial cells were observed using 
Eclipse Nikon 80i fluorescent microscope.
Microscale thermophoresis. Microscale thermophoresis experiments were carried out using Monolith 
NT.115 (NanoTemper Technologies GmbH, Germany). LssSH3b was labeled with the NT-647-NHS fluores-
cent dye according to the supplied labeling protocol Monolith NT™ Protein Labeling Kit. A series of dilutions 
of pentaglycine were prepared using buffer solution containing 100 mM glycine pH 10 and 100 mM NaCl. The 
enzyme was prepared in the same buffer. The solution of labeled LssSH3b was mixed 1:1 with different concen-
trations of pentaglycine yielding a final concentration of 10 nM of the enzyme and pentaglycine in the range of 
final concentrations between 0.2 and 17.0 mM. After 10 min of incubation, the NT.115 capillaries (NanoTemper 
1 2Scientific RepoRts |          (2019) 9:5965  | https://doi.org/10.1038/s41598-019-42435-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
Technologies) were filled with the enzyme/peptide solution and the thermophoresis was measured at a LED 
power of 100% and an MST power of 60%. The Kd was determined by nonlinear fitting of the thermophoresis 
responses using the NTAnalysis software.
scatchard analysis. S. aureus cells in PBS buffer were mixed with LssSH3b_GFP (2 to 5 µM) and incubated 
for 5 min at room temperature. The number of cells was determined before for each experiment and was in the 
range from 3,31*108 to 1,2*109 cells/ml. The mixture was centrifuged and free LssSH3b_GFP was obtained in the 
supernatant, while bound fraction was collected in the cell palette. The fluorescence of both fractions was meas-
ured using Tecan Infinite M1000 plate reader in 96 well plates using excitation at 480 nm and emission at 508 nm. 
All experiments were done in triplicates and repeated three times. The ratio of bound to free LssSH3b_GFP was 
plotted as a function of the concentration of bound. The Kd was determined by Scatchard analysis. A plot of free 
versus bound LssSH3b_GFP yields a straight line of slope (−1⋅Kd–1) which intercept on the X-axis indicate the 
value of maximum concentration of bound LssSH3b_GFP.
turbidity reduction assay. Various strains of S. aureus were cultivated in tryptic soy broth (TSB) to an 
optical density of approximately OD595 ~ 0.6. Then the bacterial suspension was centrifuged for 10 minutes at 
2500xg and the resulting bacterial pellet suspended in appropriate buffer. The optical density of the bacteria was 
adjusted to OD595 = 1.0. The test was performed on 96-well plates. If not otherwise, 100 nM enzyme were used in 
assays and the effect of their activity was observed in iMark™ Microplate Absorbance Reader (Biorad) at 595 nm. 
The measurements were made every 10 minutes for one hour at room temperature. Additional controls were run 
for the enzymes used in the assays: the MS confirmed that all enzyme preparations were homogenous and that the 
proteins used in the assays carried correct substitutions.
Binding pockets prediction. Binding pockets of the lysostaphin SH3b protein domain (PDB ID: 5LEO) 
were prediction and their druggability was assessed using the DogSiteScorer webserver25 on the basis of the “chain 
B” representation of the 5LEO crystallographic structure.
Molecular modeling of the SH3 domain-peptidoglycan complex. The SH3b domain’s structure was 
processed using Chimera v1.11.249: all heteroatoms were removed and a dockprep protocol with its default set-
tings was applied. The simplified (i.e., lacking the glycan backbone of alternating units of N-acetylglucosamine 
and N-acetylmuramic acid) peptidoglycan fragment (PG fragment, Figs S5, S6) was modeled on the basis of the 
crystallographically determined structure of the pentaglycine complexed with the SH3b protein domain (PDB 
ID: 5LEO). The three-dimensional model of structure of this PG fragment was modeled by merging the missing 
oligopeptides (i.e., bridge link and cross link in the Fig. 5, pane A) with the pentaglycine template followed by the 
optimizationwith the obminimize program of the Open Babel package v2.4.050 using the MMFF94 force field. Set 
of 313355 conformers of the ligand with a frozen pentaglycine core were generated using confab application51, 
and scored with the rDock dock_solv scoring function52. The top scoring 50% poses were selected using KNIME 
Analytics Platform53, and clustered with the root-mean-square deviation (RMSD) cutoff of 6Å. The five most 
populated clusters were then inspected visually and two representative poses were selected to reflect the potential 
binding modes of the ligand (see: Results and discussion). They were further fine-tuned manually to maximize 
the hydrogen bond interactions with the SH3b protein domain and became the starting conformers of the ligand 
for the further modelling at Molecular Mechanics level. The SH3b complex with GGSGG peptide was determined 
using molecular docking with rDock docking program with dock_solv scoring function.
Molecular dynamics study of the SH3b protein domain - PG fragment complex. DFT calcu-
lations at the HandHLYP/6–311 g(d,p) level54,55 have been performed to model the molecular properties and 
geometry (atomic charges, bond lengths, angles and torsions) of the ligand using ORCA v4.0.1 program pack-
age56. [D3] These results were used to build the ligand unit and adjust the AMBER99SB-ILDN force field57 for 
Molecular Mechanics (MM) calculations of the protein - ligand complex, performed using the GROMACS v5.0.7 
Molecular Dynamics (MD) package58,59. The force field structural parameters have been modified according to 
the DFT results54 to reproduce more realistically molecular properties of the studied system and to obtain more 
reliable morphologies of the protein – ligand complex from the MM simulations. To validate the correctness of 
the two previously selected poses from the initial molecular modelling, a series of MM calculations in explicit 
solvent (TIP4P) [D7] have been performed. The starting configuration included SH3b protein domain with: (i) 
the ligand in the two selected poses, (ii) pentaglycine positioned as in the 5LEO structure, and (iii) both oligo-
peptides positioned as in the pose with the ligand bound tightly with the SH3b domain. The procedure was to 
minimize the energy (at 0 K) of the starting configurations. Then, for each stable optimized structure, a set of 
dozens short (few ns) quenched Molecular Dynamics (NVT followed by NpT) simulations (at 600 K and 300 K) 
were performed. The simulations at 300 K have been employed to check the stability of the ligand-SH3b complex, 
while at 600 K used to explore the conformational space of the ligand upon interaction with the SH3b domain. 
The procedure was terminated once the most stable poses of ligand were identified.
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